Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ATX-559 |
| Synonyms | |
| Therapy Description |
ATX-559 is a small molecule inhibitor of DHX9, which potentially inhibits tumor cell proliferation and tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 1758). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ATX-559 | ATX 559|ATX559 | ATX-559 is a small molecule inhibitor of DHX9, which potentially inhibits tumor cell proliferation and tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 1758). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06625515 | Phase I | ATX-559 | First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients with Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers | Recruiting | USA | 0 |